Dissertations / Theses on the topic 'Osteoporotic fractures'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 dissertations / theses for your research on the topic 'Osteoporotic fractures.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse dissertations / theses on a wide variety of disciplines and organise your bibliography correctly.
Kaptoge, Stephen Kipkemoi. "Epidemiology of risk factors for osteoporosis and osteoporotic fractures." Thesis, University of Cambridge, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.615203.
Full textMisra, Devyani. "Warfarin use and risk of osteoporotic fractures." Thesis, Boston University, 2012. https://hdl.handle.net/2144/21219.
Full textOBJECTIVE: Prior studies examining the association of warfarin use and osteoporotic fractures have found conflicting results and have had methodological problems, such as confounding by indication and confounding by duration of warfarin use. Thus, we studied the association of warfarin use with fractures at the hip, spine and wrist, among older men and women with atrial fibrillation recruited from the general population, using rigorous statistical tools to overcome challenges faced by prior studies. METHODS: We included men and women ≥65 years with incident atrial fibrillation, without history of fracture, followed between 2000-2010 from The Health Improvement Network (THIN). Long-term warfarin use was defined in two ways: 1) warfarin use ≥ 1year; 2) warfarin use ≥3 years. Non-use was defined as no use of warfarin over the follow-up period. Propensity scores (PS) for warfarin use were calculated using logistic regression with long-term use of warfarin as the dependent variable and age, sex, body mass index (BMI), history of multiple falls, deep venous thrombosis, pulmonary embolism, heart failure, neuropsychiatric impairment, hyperthyroidism, estrogen use, beta blockers, corticosteroids, bisphosphonates, smoking and alcoholism as independent variables. Each warfarin user was then matched by PS to a non-user by the “greedy matching” method. Incidence rates were calculated for warfarin users and non-users. The association between long-term warfarin use and risk of hip, spine and wrist fractures was evaluated using Cox-proportional hazards models. RESULTS: Incidence rates of hip fracture were 5.21 and 6.20 per 1000 person-years among subjects with warfarin use >1 (n=20,346) and >3 (n=11,238) years, respectively. The hazard ratios of hip fracture for warfarin use >1 and >3 years were 1.08 (95% CI 0.87, 1.35) and 1.13 (95% CI: 0.84, 1.5), respectively. Similar findings were observed between warfarin use and risk of spine or wrist fracture. CONCLUSIONS: Long-term use of warfarin among older adults with atrial fibrillation is not associated with increased risk of osteoporotic fractures and thus, does not necessitate additional surveillance or prophylaxis.
2031-01-01
Tan, Boon-Kiang. "Non-invasive determinants of osteoporotic fracture risk." University of Western Australia. Centre for Musculoskeletal Studies, 2005. http://theses.library.uwa.edu.au/adt-WU2005.0125.
Full textRidzwan, Mohamad. "A computational orthopaedic biomechanics study of osteoporotic hip fractures." Thesis, Imperial College London, 2016. http://hdl.handle.net/10044/1/47971.
Full textKorpelainen, R. (Raija). "Exercise and risk factors of osteoporotic fractures in elderly women." Doctoral thesis, University of Oulu, 2005. http://urn.fi/urn:isbn:9514278054.
Full textHallberg, Inger. "Health-Related Quality of Life in Postmenopausal Women with Osteoporotic Fractures." Doctoral thesis, Linköpings universitet, Omvårdnad, 2009. http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-51524.
Full textGao, Xin. "Economic evaluation of three preventive drug therapies for osteoporotic fractures among women at different risk levels." Morgantown, W. Va. : [West Virginia University Libraries], 2001. http://etd.wvu.edu/templates/showETD.cfm?recnum=2045.
Full textTitle from document title page. Document formatted into pages; contains xi, 211 p. : ill. (some col.). Vita. Includes abstract. Includes bibliographical references (p. 171-186).
Slavens, Melanie Jean. "Milk Intake in Early and Late Adulthood and Risk of Osteoporotic Hip Fractures in Utah." DigitalCommons@USU, 2006. https://digitalcommons.usu.edu/etd/5532.
Full textDodds, R. A. "Structural and metabolic studies on normal and pathological bone." Thesis, Brunel University, 1985. http://bura.brunel.ac.uk/handle/2438/4870.
Full textBienert, Michaela [Verfasser], Wilhelm [Akademischer Betreuer] Jahnen-Dechent, and Sabine [Akademischer Betreuer] Neuß-Stein. "Biologically active bone replacement materials for osteoporotic fractures / Michaela Bienert ; Wilhelm Jahnen-Dechent, Sabine Neuß-Stein." Aachen : Universitätsbibliothek der RWTH Aachen, 2018. http://d-nb.info/1181192919/34.
Full textWagner, Helene. "Genetic and Environmental Influences on Bone and Fractures." Doctoral thesis, Uppsala universitet, Ortopedi, 2012. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-169598.
Full textLeach, Martha Ettrusia. "Risk factors for osteoporotic fractures in Black South African men : a case control study / Martha Ettrusia Leach." Thesis, North-West University, 2003. http://hdl.handle.net/10394/272.
Full textThesis (M.Sc. (Dietetics))--North-West University, Potchefstroom Campus, 2004.
Chiarello, Eugenio <1981>. "Evaluation of the Effectiveness of Femoral Neck Prophylactic Surgery in Elderly Osteoporotic Patiens to Prevent Hip Fractures." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2016. http://amsdottorato.unibo.it/7302/.
Full textMoayyeri, Alireza. "Risk assessment for osteoporotic fractures among men and women from a prospective population study : the EPIC-Norfolk study." Thesis, University of Cambridge, 2012. https://www.repository.cam.ac.uk/handle/1810/243860.
Full textLow, Adrian Kah Wai Clinical School Prince of Wales Hospital Faculty of Medicine UNSW. "The molecular biology of cancellous bone defects and oestrogen deficiency fractures, in rodents; and the in vivo effects of acid on bone healing." Publisher:University of New South Wales. Clinical School - Prince of Wales Hospital, 2008. http://handle.unsw.edu.au/1959.4/42884.
Full textNyandege, Abner. "ASSOCIATION BETWEEN CONCOMITANT USE OF BISPHOSPHONATES AND SEROTONIN REUPTAKE INHIBITORS AND INCREASED RISK OF OSTEOPOROTIC-RELATED FRACTURES: AMONG COMMUNITY-DWELLING POSTMENOPAUSAL WOMEN." VCU Scholars Compass, 2013. http://scholarscompass.vcu.edu/etd/557.
Full textGunnella, Francesca [Verfasser], Raimund W. [Gutachter] Kinne, Michael [Gutachter] Sittinger, and Reinhard [Gutachter] Wetzker. "Biotechnologically modified calcium phosphate cement for the stabilization of osteoporotic vertebral compression fractures / Francesca Gunnella ; Gutachter: Raimund K. Kinne, Michael Sittinger, Reinhard Wetzker." Jena : Friedrich-Schiller-Universität Jena, 2019. http://d-nb.info/1206098716/34.
Full textMartínez, Laguna Daniel. "Efecto de la diabetes mellitus tipo 2 sobre la incidencia de fractura osteoporótica." Doctoral thesis, Universitat Autònoma de Barcelona, 2017. http://hdl.handle.net/10803/457525.
Full textAims: Type 2 diabetes mellitus (T2DM) and osteoporosis are two highly prevalent long-term comorbidities. Paradoxically, although T2DM patients have a higher bone mass, they present an increased risk of fracture. The objectives of this study are to estimate the association between the presence of T2DM and the incidence of osteoporotic fracture in the Spanish population and secondarily to analyze the relationship between T2DM and all-cause mortality after an osteoporotic fracture. Methods: Population-based cohort study. For sub-study 1, patients with incidentT2DM between 2006-1013 from the SIDIAP database were selected and matched with 2 non-diabetic patients. For sub-study 2 T2DM patients ≥50 years between 2006-2013 were selected and were matched with 2 non-diabetic subjects. Information about risk factors, incident fractures, mortality and confounding factors were collected. Survival models of Fine and Gray were fitted to model the association between T2DM and hip fracture risk. Post-fracture mortality rates were calculated for sub-study 2 and Cox regression models were fitted to calculate mortality risk according to T2DM status. Results: 58,483 patients with incident T2DM and 113,448 non-diabetic patients were selected, followed by a median (interquartile range) of 2.63 (2.93) years. In the early years (up to 6) following disease onset, 444/58,483 (0.8%) T2DM patients sustained a hip fracture, compared to 776/113,448 (0.7%) matched non-diabetic controls. The adjusted SHR was 1.20 [95% CI 1.06 - 1.35]. In sub-study 2, a total of 166,106 T2DM and 332,212 non-diabetic patients were identified, of whom 11,066 (6.66%) T2DM and 21.564 (6.49%) non-diabetic patients sustained a fracture, and were then included for the main analysis Mortality rate post-fracture was 53.93 per 1,000 person-years. More than 50% of the observed deaths occurred during the first two years after a fracture, with the higher proportion of them seen in the first year following a hip fracture. The adjusted HR mortality post-fracture was 1.30 [95% CI 1.23-1.37]. Conclusions: Recently diagnosed T2DM patients have a 20% higher risk of hip fractures in the first few years following disease onset, compared to non-diabetic patients. T2DM patients have a 20-30% excess all-cause mortality following a fracture, with a higher mortality rate after a femoral fracture.
Sousa, Cristina de Jesus. "An?lise do risco de fraturas ?sseas nas mulheres idosas por meio da ferramenta FRAX." Universidade Cat?lica de Bras?lia, 2018. https://bdtd.ucb.br:8443/jspui/handle/tede/2498.
Full textApproved for entry into archive by Sara Ribeiro (sara.ribeiro@ucb.br) on 2018-11-19T13:39:46Z (GMT) No. of bitstreams: 1 CristinadeJesusSousaDissertacaoParcial2018.pdf: 780979 bytes, checksum: d8b80ee196a8840b1efaee7d6dcb18f5 (MD5)
Made available in DSpace on 2018-11-19T13:39:46Z (GMT). No. of bitstreams: 1 CristinadeJesusSousaDissertacaoParcial2018.pdf: 780979 bytes, checksum: d8b80ee196a8840b1efaee7d6dcb18f5 (MD5) Previous issue date: 2018-07-30
This is a quantitative, cross-sectional and descriptive study whose general objective was to evaluate the bone quality of elderly women with more than 60 years of age attending a general gynecology clinic in the Distrito Federal, through the application of the FRAX Tool. The study site was a private general gynecological clinic and the sample consisted of 147 were elderly women (60 to 90 years). For the data collection, three instruments were used: a sociodemographic questionnaire, the FRAX tool and the FRAQ-Brazil instrument. Comparisons of proportions between two independent groups were performed using Fisher's exact test. Categorical variables were described with counts and proportions. Quantitative variables of normal and asymmetric distribution were described as mean ? standard deviation and median (interquartile range) respectively. Normality was assessed by visual inspection of histograms. The R software was used in the statistical analysis of data. All probabilities of significance are bilateral and values less than 0.05 are considered statistically significant. The results obtained are found in articles 1 and 2. The research allowed an intense literature review to contribute to an understanding of which factors limit the use of the FRAX Tool, and which groups of older people should be better and more carefully analyzed for orientation. We found a mean and high risk of osteoporotic fractures assessed by applying the FRAX tool in non-elderly patients by 0.3%, in elderly patients up to 79 years old was found in 3,7% and in 45,5% of the elderly women above of 80 years. It can be concluded that the FRAX tool, despite some limitations, is important for the early identification and screening of individuals at risk of fractures due to its simplicity of application, allowing early and safe therapeutic decision making. It was also concluded that there is a significant increase in the risk of osteoporotic fractures with advancing age.
Trata-se de um estudo quantitativo, transversal e descritivo cujo objetivo geral foi avaliar a qualidade da massa ?ssea de idosas com mais de 60 anos frequentadoras de uma cl?nica de ginecologia geral no Distrito Federal, por meio da aplica??o da Ferramenta FRAX. O local do estudo foi uma cl?nica particular de ginecol?gica geral e a amostra foi constitu?da 147 mulheres idosas (60 a 90 anos). Para a coleta de dados, utilizaram-se tr?s instrumentos: um question?rio sociodemogr?fico, a Ferramenta FRAX e o instrumento FRAQ-Brasil. Compara??es de propor??es entre dois grupos independentes foram efetuadas utilizando-se teste exato de Fisher. Vari?veis categ?ricas foram descritas com contagens e propor??es. Vari?veis quantitativas de distribui??o normal e assim?trica foram descritas como m?dia ? desvio padr?o e mediana (intervalo interquartil) respectivamente. Normalidade foi avaliada com a inspe??o visual de histogramas. O software R foi utilizado na an?lise estat?stica de dados. Todas as probabilidades de signific?ncia apresentadas s?o do tipo bilateral e valores menores que 0.05 considerados estatisticamente significantes. Os resultados obtidos encontram-se nos artigos 1 e 2. A pesquisa permitiu a realiza??o de uma intensa revis?o de literatura visando contribuir para uma compreens?o de quais fatores limitam o uso da Ferramenta FRAX, e quais grupos de idosos devem ser melhores e mais cuidadosamente analisados para a orienta??o. Encontrou-se m?dio e alto risco de fraturas osteopor?ticas avaliado atrav?s da aplica??o da Ferramenta FRAX nas pacientes idosas aos 79 anos o percentual encontrado foi de 3,7% e em 45,5% nas idosas acima dos 80 anos. Pode-se concluir que a Ferramenta FRAX, apesar de algumas limita??es, ? importante para a identifica??o precoce e o rastreamento de indiv?duos com risco de fraturas, devido ? sua simplicidade de aplica??o, permitindo uma tomada de decis?o terap?utica precoce e segura. Concluiuse tamb?m que h? um aumento importante do risco de fraturas osteopor?ticas com o avan?ar da idade.
Braz, Manuela Giuliani Marcondes Rocha. "Sequenciamento paralelo em larga escala de genes candidatos para fragilidade óssea em indivíduos com osteoporose grave, familiar ou idiopática." Universidade de São Paulo, 2018. http://www.teses.usp.br/teses/disponiveis/5/5135/tde-22102018-123623/.
Full textOsteoporosis is a highly prevalent disorder resulting in fragility fractures and incurring in great morbi-mortality and economic burden. In most cases, osteoporosis has a multifactorial etiology, with an estimated heritability of 50-85% attributable to a combination of several low-impact genetic variants. Rarely, cases of syndromic osteoporosis due to high-impact genetic defects are seen. It is therefore hypothesized that severe/idiopathic cases of otherwise inconspicuous osteoporosis may have a monoor oligogenic etiology due to genetic variants with an intermediate effect. During the past years, advances in molecular sequencing have revealed novel candidate genes for bone fragility, and have enabled simultaneous sequencing of multiple genes. In this context, the objectives of this research project were: 1) to identify candidate genes for bone fragility, as previously reported in association to Mendelian disorders with high impact on bone resistance, idiopathic or familial osteoporosis, and genome-wide association studies (GWAS) for bone mineral density and fragility fractures; and 2) to perform molecular analysis of these candidate genes in patients with severe, familial or idiopathic osteoporosis. Through a systematic review, 128 candidate genes were identified and included in a panel for massively parallel sequencing. Coding regions and 25-bp boundaries were captured and sequenced. Rare variants (allele frequency < 1%), with a predicted high impact on protein function were initially selected as variants of interest. Thirty-seven subjects (21 sporadic cases and 7 families) were included according to stringent criteria based on clinical and densitometric evaluation, excluding individuals with secondary osteoporosis. Males represented 54% of the cohort, median age at diagnosis was 44 years, and 84% of subjects had a history of fractures. Thirtythree variants of interest were identified initially. After familial segregation analysis, 5 variants were considered as benign in regard to bone fragility, resulting in 28 potentially pathogenic variants, all heterozygous, present in 71% of the cohort. Of these variants, 26 were nonsynonymous, there was one 9-bp deletion and one large deletion involving the only coding exon of candidate gene GPR68. An association of two or more variants in different genes was present in 21% of the cohort, including a young woman with severe osteoporosis and variants in WNT1, PLS3 and NOTCH2. Familial segregation in this case suggested an additive pathogenic effect of these variants. Twenty-five percent of potentially pathogenic variants were identified in well-established candidate genes (WNT1, PLS3, COL1A1, COL1A2), and 57% located to novel candidate genes initially identified by GWAS, such as NBR1 and GPR68, which have been previously associated to changes in bone remodeling in mouse models. These results support the involvement of GWAS genes in the pathophysyiology of osteoporosis, and indicate a prominent role for digenic/oligogenic interactions in cases of severe, familial or idiopathic osteoporosis. Recognition of new molecular pathways in the determination of bone fragility may lead to the development of new drugs, and the identification of pathogenic variants associated to osteoporosis may allow individualized clinical management of patients and their relatives
Bastos-Silva, Yasmin 1990. "Correlação do risco de fratura osteoporótica em 10 anos calculado pelo FRAX com e sem densitometria em mulheres brasileiras na pós menopausa = Correlation between osteoporotic fracture risk in 10 years calculated by FRAX with and without bone densitometry in post menopause brazilian women." [s.n.], 2015. http://repositorio.unicamp.br/jspui/handle/REPOSIP/312826.
Full textDissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas
Made available in DSpace on 2018-08-27T21:42:31Z (GMT). No. of bitstreams: 1 Bastos-Silva_Yasmin_M.pdf: 1080942 bytes, checksum: 7599dbea7c337dddf84a74226180fc92 (MD5) Previous issue date: 2015
Resumo: O risco de fratura osteoporótica pode ser avaliado clinicamente baseado em fatores clínicos e pela densidade mineral óssea (DMO), entretanto esses parâmetros não são bons preditores do risco de fratura. Recentemente, o Brasil foi incluído no instrumento fracture risk assessment tool- FRAX-BRASIL, porém seu uso tem sido limitado na prática clínica. OBJETIVO: Avaliar o grau de concordância entre o risco de fratura em 10 anos calculado pelo FRAX-BRASIL com e sem densitometria em mulheres brasileiras na pós-menopausa. MÉTODO: Realizou-se um estudo de corte transversal no período de novembro de 2014 a fevereiro de 2015, com 402 mulheres em acompanhamento no Ambulatório de Menopausa do Hospital da Mulher Prof. Dr. José Aristodemo Pinotti em Campinas-SP. Foram incluídas mulheres com 40 anos ou mais, em amenorreia há pelo menos 12 meses e com exame de densitometria óssea prévio a qualquer tratamento medicamentoso para osteopenia ou osteoporose. As mulheres foram entrevistadas por um pesquisador durante a consulta de rotina, na qual foram coletadas informações sobre fatores de risco necessários para o questionário FRAX-BRASIL e dados da densitometria óssea. Os dados obtidos foram inseridos na plataforma online FRAX-BRASIL, em que foi calculado o risco para uma fratura maior e de quadril, utilizando-se somente os fatores de risco clínicos e o risco incluindo valores de DMO do colo do fêmur em g/cm2. ANÁLISE ESTATÍSTICA: Para análise do grau de concordância entre os riscos de fraturas com e sem densitometria óssea foi utilizado o coeficiente de correlação intraclasse (ICC). O Teste de Mann-whitney foi utilizado para comparação entre as médias do risco de fratura calculado com e sem DMO; para comparação entre as frequências de alto risco calculadas com e sem DMO foi utilizado o Teste de comparação entre duas proporções. Para análise da associação entre as variáveis clinico/demográficas e a variação do risco de fratura foi utilizada a análise de regressão linear. O nível de significância adotado foi <0,05. RESULTADOS: A probabilidade de fratura em 10 anos calculada pelo FRAX-BRASIL para fratura de quadril e para fratura maior somente pelos fatores de risco clínicos foi de 0,84% ±1,92 e 4,03% ±2,98 e com DMO foi de 0,83% ±1,76 e 4,05% ±2,98 respectivamente. O coeficiente de correlação intraclasse entre o FRAX-BRASIL com e sem DMO foi de 0,76 (IC95% 0,716-0,799) para uma fratura maior e de 0,644 (IC95% 0,583-0,698) para fratura de quadril. Ao avaliar as mulheres utilizando o FRAX com DMO 0,75% e 5,22% excederam os limiares de alto risco para fratura maior e de quadril, respectivamente. Sem o acréscimo da densidade óssea 1% e 11,44% apresentaram alto risco para fratura maior e de quadril, respectivamente. Dessa forma a recomendação de tratamento foi concordante entre o FRAX com e sem DMO em 99,75% dos casos de alto risco de fratura maior e de 93,78% para o quadril. Os fatores associados a menor variação FRAX com e sem foram maior idade, menor DMO, menor T-score e ausência de fratura previa tanto para fratura maior como para quadril. O menor IMC esteve associado a menor variação do FRAX apenas para fratura maior. CONCLUSÃO: O risco de fratura maior ou de quadril foi baixo na população estudada. O FRAX-BRASIL apresentou alta concordância para estimar o risco de fratura maior e concordância moderada para fratura de quadril apresentando uma estimativa de risco para fratura semelhante com ou sem DMO em nossa população
Abstract: The risk of osteoporotic fracture can be clinically evaluated based on clinical factors and by the bone mineral density (BMD), but these parameters are not good predictors of fracture risk. Recently, Brazil was included in the fracture risk assessment tool- FRAX-BRAZIL, but its use has been limited in clinical practice. GOAL: To evaluate the degree of correlation between the degree of correlation between the risk of fracture in 10 years calculated by FRAX-BRAZIL with and without densitometry in Brazilian postmenopausal women. METHODS: A cross-sectional study was conducted with 402 women followed up at the Menopause Ambulatory at the Women's Hospital Prof. Dr. José Aristodemo Pinotti in Campinas-SP. Women were included with 40 years or more in amenorrhea for at least 12 months and with bone densitometry exam prior to any drug treatment for osteopenia or osteoporosis. A researcher interviewed the women during a routine visit, where information about risk factors necessary for the FRAX-BRAZIL questionnaire and data of bone densitometry were collected. The collected data were inserted on the online platform FRAX-BRAZIL where the risk for major fractures and of the hip using only clinical risk factors and the risk including femoral neck BMD values in g / cm2. STATISTICAL ANALYSIS: To analyze the degree of correlation between the risk of fractures with and without bone densitometry was used the intraclass correlation coefficient (ICC). The Mann-Whitney test was used to compare the averages of fracture risk calculated with and without BMD; to compare the frequencies of high risk calculated with and without BMD was used the compare Test between two proportions. For analysis of the association between clinical / demographic variables and the change of the fracture risk was used linear regression analysis. The significance level was <0.05. RESULTS: The fracture probability calculated in 10 years by using the FRAX-BRAZIL for hip fracture and major fracture only by clinical risk factors was 0.84% ± 1.92 and 4.03 ± 2.98% and BMD was 0.83% ± 1.76 and 4.05 ± 2.98%, respectively. The intraclass correlation coefficient between the FRAX-BRAZIL with and without BMD was 0.76 (IC95% 0.716-0.799) for a major fracture and 0.644 (IC95% 0.583-0.698) for hip fracture. When evaluating women using FRAX with BMD 0.75% and 5.22% exceeded the high-risk thresholds for major and hip fracture, respectively. Without the increase of the bone density 1% and 11.44% presented high risk for major fractures and of hip, respectively. Then the treatment recommendation was consistent between the FRAX with and without BMD in 99.75% of cases of high risk of major fracture and 93.78% for the hip. Factors associated with less variation FRAX with and without were older, lower BMD, lower T-score, and no previous fracture both for major fracture as to hip fracture. The BMI was associated with lower variation in the FRAX only to major fracture. CONCLUSION: The risk of major fracture or of the hip was low in the study population. The FRAX-BRAZIL presented a high correlation to estimate the risk of major fractures and moderate agreement for hip fracture presenting a risk estimate for similar fracture with or without BMD in our population. The FRAX-BRAZIL presented a high correlation to estimate the risk of major fractures and moderate correlation for hip fracture presenting a risk estimate for similar fracture with or without BMD in our population
Mestrado
Fisiopatologia Ginecológica
Mestra em Ciências da Saúde
Stefani, Kelly Cristina. "Relação do polimorfismo do receptor P2X7 com a densidade mineral óssea: estudo em pacientes idosos com fraturas do tornozelo." Universidade de São Paulo, 2018. http://www.teses.usp.br/teses/disponiveis/5/5140/tde-28022019-100221/.
Full textThe purpose of this study was to determine whether a genetic variation in the P2X7 receptor gene is associated with reduced bone mineral density and the risk of osteoporosis in patients over 50 years of age with ankle fractures. A Level-1 diagnostic study was conducted. Patients over 50 years of age with ankle fractures who had undergone surgical treatment were divided into two groups following the result of a bone densitometry: a study group with osteopenia (bone mineral density T score between -1 and -2.5) or osteoporosis (bone mineral density T score <= -2.5) and the control group with normal values (bone mineral density T score >= -1). Exclusion criteria were alterations that led to secondary osteoporosis. Patients were genotyped for 15 nonsynonymous single nucleotide polymorphisms (SNPs) within the P2X7 receptor (numbered from 1 to 15) obtained from saliva. We evaluated 121 patients with ankle fractures, 56 being from the control group, and 65 from the study group. All patients were sedentary, did not take any medication for the treatment of osteoporosis, did not smoke, and had suffered a low-impact trauma. The grouped assessment of the SNP alterations showed that if a gene has three or more SNP variants (36.4% of the 121 patients), out of the 15 possibilities, it is altered with clinical repercussions related to the loss or gain of the function of the gene. In evaluating the SNP alterations individually, the results suggest that: SNPs 1,4,14, and 15 are loss of function variants; SNPs 5 and 10 are described as loss of function variants; however, they have no influence on our study population; SNPs 11 and 13 are loss of function variants and not gain of function function as is described in the literature; and SNP 12 was associated with a loss of function in our population. In conclusion, we showed that the functional polymorphisms in P2X7 are associated with Bone Mineral Density and the risk of ankle fractures. As limitations to our study, we can point out the fact that we focused mainly on nonsynonymous polymorphisms, which do not cover all the genetic variations in P2X7, and the small number of participants when compared to the world literature. On the other hand, a strength of our study is that it was the first to assess P2X7 in the Brazilian population, which is quite heterogeneous from the genetic point of view due to our miscegenation, as compared to other studies that evaluated the population of northern Europe, which is genetically more homogeneous. In conclusion, the SNP12 polymorphism in P2X7 is associated with Bone Mineral Density and the risk of ankle fractures
Ferreira, Neville de Oliveira 1982. "Prevalência de fratura vertebral, alterações radiológicas, dor nas costas, qualidade de vida em mulheres com osteoporose pós-menopausa e validação da versão na língua portuguesa do questionário de qualidade de vida QUALEFFO-41." [s.n.], 2011. http://repositorio.unicamp.br/jspui/handle/REPOSIP/308725.
Full textTese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas
Made available in DSpace on 2018-08-18T22:13:15Z (GMT). No. of bitstreams: 1 Ferreira_NevilledeOliveira_D.pdf: 2260205 bytes, checksum: 4735926d615eaa3b10d11ae68acd6940 (MD5) Previous issue date: 2011
Resumo: Objetivo: Avaliar a prevalência de fratura vertebral, alterações radiológicas, dor nas costas, e associação com qualidade de vida em mulheres com osteoporose pós-menopausa e validar a versão na língua portuguesa do questionário de qualidade de vida QUALEFFO-41 em mulheres brasileiras com fratura vertebral. Métodos: Este estudo coletou dados de 126 mulheres com osteoporose e 43 mulheres sem osteoporose. O estudo de prevalência de fratura vertebral (FV), osteófitos e dor nas costas, foi um corte transversal com o total de 126 mulheres com osteoporose lombar pós-menopausa diagnosticada pela densitometria óssea selecionadas no Ambulatório de Menopausa do CAISM. As mulheres responderam entrevista sobre dados sociodemográficos e clínicos, e o questionário QUALEFFO-41. Todas realizaram radiografia de coluna para pesquisa de alterações radiológicas. Para a análise estatística utilizou-se os testes de Mann-Whitney ou T de Student, testes exato de Fisher ou qui-quadrado e regressão múltipla. O estudo de validação do QUALEFFO-41 foi realizado apenas com 43 com FV por osteoporose (grupo fratura) e 43 sem osteoporose (grupo controle), pareadas por idade (±3 anos). Foram aplicados o QUALEFFO-41 e o SF-36 (comparação teste-reteste). Calculou-se o coeficiente ? de Cronbach, coeficiente de Correlação Intraclasse, coeficiente Kappa (k), Odds ratio e curva ROC. Resultados: Os resultados foram apresentados em três artigos. No primeiro artigo, a prevalência de FV nas 126 mulheres foi de 34,1% e o tipo de FV mais prevalente foi a triangular anterior (45,9%). Não houve diferença na qualidade de vida (QV) entre as mulheres com osteoporose com e sem FV, porém o maior número de fraturas associou-se a pior QV. Os fatores associados à pior QV foram cor da pele não branca, obesidade, ausência de trabalho remunerado, sedentarismo, baixa escolaridade e não uso de medicação para osteoporose. No segundo artigo sobre prevalência de alterações radiológicas e dor nas costas, a prevalência de FV foi de 34,1 % e de osteófitos de 92,1%. A prevalência de dor nas costas foi de 66,7% e observou-se associação entre a dor nas costas com a presença de osteófitos (p=0,0157) e pior QV. No terceiro artigo de validação do QUALEFFO-41, o coeficiente ? de Cronbach dos domínios variou entre 0,74 e 0,84; o ICC dos domínios variou entre 0,67 e 0,90; a maioria das questões apresentou um coeficiente k maior do que 0,50 e demonstrou boa validade convergente e discriminante. As mulheres do grupo FV apresentaram comprometimento na QV em ambos os questionários (p<0,05) e houve boa correlação entre os domínios do QUALEFFO-41 e os seus correspondentes do SF-36, exceto para Função Social. A avaliação pela curva ROC e regressão logística demonstrou que todos os domínios do QUALEFFO-41 foram significativamente preditivos de FV. Conclusão: A prevalência de FV por osteoporose foi alta, com comprometimento na QV independente da FV. Também houve uma alta prevalência de dor nas costas associada à presença de osteófitos e pior QV. O QUALEFFO-41 na língua portuguesa pode ser utilizado em mulheres brasileiras com FV por osteoporose, pois mostrou ter boas características psicométricas, demonstrando comprometimento na QV e boa capacidade de discriminar a QV em mulheres com FV
Abstract: Objective: To evaluate the prevalence of vertebral fractures, radiographic abnormalities, back pain, and association with quality of life in women with postmenopausal osteoporosis, and to validate the Portuguese version of the quality of life QUALEFFO-41 questionnaire in Brazilian women with osteoporosis vertebral fractures. Methods: This study was conducted with a total of 126 women with osteoporosis and 43 women without osteoporosis. The study of the prevalence of vertebral fractures (VF), osteophytes and back pain, was a cross sectional study with a total of 126 postmenopausal women, with lumbar osteoporosis diagnosed by bone densitometry, selected from the Menopause Outpatient Clinic of the Women's Integrated Healthcare Center (CAISM). The women were interviewed about sociodemographic/clinical data and the QUALEFFO-41 questionnaire. Lumbar spine radiograph was performed in all participants to study radiographic abnormalities. The statistical analysis was performed by the Mann-Whitney or Student's T-test, Fisher's Exact or Chi-square, and multiple regression. The QUALEFFO-41 validation study was conducted with only 43 women with osteoporosis VF (fracture group) and 43 women without osteoporosis (control group), age-matched (±3 years). The QUALEFFO-41 questionnaire was administered twice in four weeks and compared to SF-36 (testretest). For analysis were calculated the Cronbach's ? Coefficient, the Intraclass Correlation Coefficient, the Kappa's Coefficient, Odds ratio and ROC curve. Results: The results were presented in three articles. In the first, the prevalence of VF in the 126 women was 34,1% and the most prevalent type of VF was anterior wedge (45.9%). No difference was observed in the quality of life (QOL) between women with osteoporosis with and without VF, although there was direct correlation between number of VF and worse QOL. Factors associated with worse QOL were non-white skin color, obesity, no paid job, sedentary lifestyle, low level of school education and non-use of osteoporosis drugs. In the second article about prevalence of radiographic abnormalities and back pain, the prevalence of VF was 34,1 % and of 92,1% to osteophytes. Back pain in the last four weeks was prevalent in 66.7% of women and it was observed a association between back pain with osteophytes presence (p=0,0157) and worse QOL. In the third article of validation of QUALEFFO-41, the Cronbach's ? coefficient of the domains ranged between 0,74 and 0,84; the ICC of the domains ranged between 0,67 and 0,90; the majority of questions showed a k coefficient higher than 0,50 and demonstrated good convergent validity and discriminant validity. The group of women with VF showed impairment in the QOL in both questionnaires (p<0,05) and there was a good correlation among the QUALEFFO-41 domains and their corresponding SF- 36 domains, except for Social Function. All QUALEFFO-41 domains were significantly predictive of VF on assessment of the ROC curve. Conclusion: The prevalence of osteoporosis VF was high, with impairment of the QOL independent of VF. There is also a high prevalence of back pain associated with osteophytes and worse QOL. The Portuguese version of the QUALEFFO-41 may be used in Brazilian women with osteoporosis VF because it shows good psychometric characteristics, the impairment of the QOL and good ability to discriminate QOL in women with osteoporosis VF
Doutorado
Fisiopatologia Ginecológica
Doutor em Ciências da Saúde
Hillier, Sharon Lee. "Water fluoridation and osteoporotic hip fracture." Thesis, University of Southampton, 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.264665.
Full textUgarte, Corbalán Laura de 1988. "The regulatory roles of MicroRNAs in bone remodeling and osteoporosis." Doctoral thesis, Universitat Pompeu Fabra, 2016. http://hdl.handle.net/10803/565403.
Full textEn l’àmbit de l’estudi de l’òs, els microRNAs (miRNAs) han estat descrits com factors claus en la regulació de la formació, remodelatge i homeòstasis de l’ òs. La identificació de miRNAs implicats en la funció esquelètica és imprescindible pel desenvolupament de noves estratègies terapèutiques, basades en miRNAs, dirigides al tractament de malalties òssies. Com en el cas d’altres molècules reguladores, els miRNAs poden patir modificacions durant el desenvolupament de malalties humanes. En aquest sentit, hem identificat un grup de miRNAs amb una expressió alterada en l’òs osteoporòtic i hem demostrat la implicació funcional d’algun d’aquests miRNAs en la regulació de la formació òssia i els mecanismes pels quals es produiria l’osteoporosi. Alhora, també hem ofert una visió general dels miRNAs presents en el teixit ossi humà i en les cèl·lules òssies. També hem identificat variants genètiques dins de les seqüències de miRNAs expressats en osteoblasts, que han estat associades amb la densitat mineral òssia. A més a més, aquesta associació ha estat funcionalment demostrada en òs i osteoblasts. Aquest treball reflexa l’elevada complexitat que hi ha darrera del sistema regulador per miRNAs i obre nous camins per la recerca i la teràpia.
Chen, Yong. "Comparative Effectiveness of Alendronate and Risedronate on the Risk of Non-Vertebral Fractures in Older Women: An Instrumental Variables Approach: A Dissertation." eScholarship@UMMS, 2011. https://escholarship.umassmed.edu/gsbs_diss/582.
Full textWindolf, Markus [Verfasser]. "Fracture fixation in osteoporotic bone / Markus Windolf." Ulm : Universität Ulm, 2014. http://d-nb.info/118442988X/34.
Full textCastillón, Bernal Pablo. "Implementación de una unidad de trauma geriátrico." Doctoral thesis, Universitat Autònoma de Barcelona, 2020. http://hdl.handle.net/10803/670446.
Full textIntroducción En el año 1990 se produjeron 1,6 millones de fracturas de cadera en todo el mundo y se estima que esa cifra aumentará a 6 millones en el año 2050. En la Unión Europea se producen 600.000 fracturas de cadera al año, aproximadamente, con un coste global anual de 13.000 millones de Euros. La incidencia en España es de 517 casos por cada 100.000 habitantes y por año. La edad media de 82 años y un 78% de los pacientes son de sexo femenino. Los objetivos del tratamiento de la fractura de cadera son preservar la vida y conseguir una recuperación funcional que permita al paciente integrarse de nuevo en su medio habitual. Pero, en estos pacientes, la tasa de mortalidad se eleva durante el primer año de un 8,4% a un 36%. Al año de la fractura el 50% presentan dificultades para caminar, el 38-39% presentan dificultades para realizar transferencias y el 17-19% presentan dificultades para el aseo. Hasta un 90% de los pacientes presentan múltiples comorbilidades, entre las que la enfermedad pulmonar obstructiva crónica, la demencia, la hipertensión arterial, la patología cardiaca isquémica y la diabetes son las más comunes. Las características de estos pacientes, ancianos y con múltiples comorbilidades, hizo surgir la idea de proporcionarles una atención compartida entre cirujanos ortopédicos y geriatras. Esa idea inicial ha evolucionado a la tendencia actual de implementar unidades de ortogeriatría que integren un tratamiento multidisciplinar. En este modelo a geriatras y traumatólogos se suman también anestesistas, rehabilitadores, fisioterapeutas, enfermeras y nutricionistas, entre otros. Objetivos El objetivo principal de esta tesis doctoral es determinar la demora para intervención quirúrgica de los pacientes con fractura de fémur proximal tras la implementación de una unidad de ortogeriatría. Los objetivos secundarios son determinar el tiempo de estancia hospitalaria, la mortalidad intrahospitalaria y a los 30 días, y los reingresos que se producen por complicaciones médicas y traumatológicas. Material y métodos Durante el año 2013 (Junio-Diciembre), 2014 y 2015, ingresaron en nuestro servicio 534 fracturas de cadera, de forma consecutiva. Mientras que en los años 2011, 2012 y 2013 (Enero-Mayo), cuando todavía no existía la Unidad de Traumatología Geriátrica (UTG) ingresaron 501. Los datos recogidos prospectivamente en el segundo periodo, tras la implementación de la UTG, han sido comparados con los datos de los pacientes que ingresaron en el primer periodo. Resultados La demora media para ser intervenido quirúrgicamente previamente a la implementación de la UTG fue de 2,27 días (DE=2,35), mientras que posteriormente fue de 1,84 (DE=1,73). (p=0,0004). La estancia media previamente a la implementación de la UTG fue de 11,39 días (DE=9,05), mientras que posteriormente fue de 10,08 (DE=5,43). (p=0,0024). La mortalidad en los primeros 30 días tras la fractura de cadera, previamente a la implementación de la UTG fue del 7,7%, mientras que posteriormente fue del 4,8%. (p = 0,027). Conclusión La implementación de una unidad de ortogeriatría, para el tratamiento de los pacientes con fractura de fémur proximal, que incluye un conjunto de medidas entre las que destacan la introducción de circuitos rápidos de tratamiento, tratamiento multidisciplinar integrado y protocolos de rehabilitación temprana postoperatoria, ha permitido disminuir de 2,27 a 1,84 días el tiempo de demora medio para ser intervenido quirúrgicamente tras el ingreso. El tiempo de estancia hospitalaria se ha reducido en un tiempo medio de un día. La mortalidad de los pacientes a los 30 días se ha reducido en un 2,9%. Los reingresos por complicaciones médicas o quirúrgicas no se han incrementado.
Introduction In 1990, there were 1.6 million hip fractures worldwide. This number is expected to reach 6 million by 2050. In the European Union, osteoporosis causes approximately 600.000 hip fractures per year. The annual estimated economic burden for healthcare systems is 13.000 million Euros. The incidence of hip fractures in Spain is 517 cases per 100.000 inhabitants and year. The average age is 82 years and 78% are women. The goal of hip fracture treatment is to return the patient to preoperative levels of function, facilitating return to pre-fracture residence and supporting long-term wellbeing. Mortality rates in hip fracture patients rise from 8.4 to 36% in the first year after surgery. One year after the fracture, 50% have difficulties in walking, 38-39% are not able to transfer from a bed to a chair and 17-19% require aids for bathing and grooming. Up to 90% of patients have several comorbidities. Commonly, these include chronic obstructive pulmonary disease, dementia, high blood pressure, ischemic heart disease, and diabetes. Elderly patients with several comorbidities could benefit from shared care approaches provided by orthopedic surgeons and geriatricians. This cooperation has triggered the current trend of implementing orthogeriatric units that integrate multidisciplinary teams. In this model, several disciplines, besides surgeons and geriatricians, are involved in the care of the patients including anesthesiologists, physical therapists, nurses, and nutritionists. Objectives The main objective of this study is to determine the delay for surgical intervention of patients with proximal femur fracture after the implementation of an orthogeriatric unit. Secondary objectives are to determine the length of hospital stay, in-hospital and 30-day mortality, and readmissions resulting from medical and trauma complications. Material and methods During 2013 (June-December), 2014, and 2015, 534 consecutive hip fractures were treated in our hospital. While in 2011, 2012, and 2013 (January-May), before the orthogeriatric unit (OGU) was created, 501 hip fractures were treated. Data collected prospectively in the second period, after the implementation of the OGU, have been compared with the first period data. Results The mean delay to undergo surgery before the implementation of the OGU was 2.27 days (SD = 2.35), compared to 1.84 (SD = 1.73). (p = 0.0004) for the second period. The average in-hospital stay before the implementation of the OGU was 11.39 days (SD = 9.05), compared to 10.08 (SD = 5.43). (p = 0.0024) after the orthogeriatric model of care was established. 30-day mortality rate after hip fracture, before OGU implementation, was 7.7%, and 4.8% afterward. (p = 0.027). Conclusion The implementation of an orthogeriatric unit for the treatment of patients with a hip fracture which requires a series of measures including the introduction of fast treatment circuits, integrated multidisciplinary treatment, and early postoperative rehabilitation protocols, has allowed a decrease from 2.27 to 1.84 days in the average time to surgery after admission. The length of hospital stay was reduced by an average time of one day. 30-day mortality was reduced by 2.9%. Readmissions for medical or surgical complications did not increase.
Herman, Elizabeth O'Brien. "The Use of Osteoporotic Medications Following a Fracture." VCU Scholars Compass, 2006. http://scholarscompass.vcu.edu/etd_retro/118.
Full textBorgström, Fredrik. "Health economics of osteoporosis /." Stockholm, 2006. http://diss.kib.ki.se/2006/91-7140-781-2/.
Full textMachado, Luana Gerheim. "Gordura visceral medida por DXA está associada com risco aumentado de fraturas não vertebrais em mulheres idosas não obesas: São Paulo Ageing e Health (SPAH) Study." Universidade de São Paulo, 2017. http://www.teses.usp.br/teses/disponiveis/5/5140/tde-15122017-120924/.
Full textIntroduction: The protective effect of obesity on bone health has been questioned because visceral fat has been demonstrated to have a deleterious effect on bone. However, to date, there have been no studies evaluating the association between visceral fat measured by dual-energy Xray absorptiometry (DXA) with fracture risk. Objective: The aim of this study was to investigate the association of visceral fat measured by DXA with the incidence of non-spine fractures in community-dwelling elderly women. Methods: This longitudinal prospective population-based cohort study evaluated 433 community-dwelling women aged 65 years or older. A clinical questionnaire, including personal history of a fragility fracture in non-spine osteoporotic sites, was administered at baseline and after an average of 4.3 years. All incidences of fragility fractures during the study period were confirmed by affected-site radiography. Visceral adipose tissue (VAT) was measured in the android region of a whole-body DXA scan through a specific software. Logistic regression models were used to estimate the relationship between visceral fat and non-spine fractures. Results: The mean age was 72.8 ± 4.7 years, and 28 incident non-spine osteoporotic fractures were identified after a mean follow-up time of 4.3 ± 0.8 years. According to the Lipschitz classification for nutritional status in the elderly, 38.6% of women were nonobese (BMI <= 27 kg/m²) and 61.4 % were obese/overweight (BMI > 27 kg/m²). After adjusting for age, race, previous fractures, and bone mineral density (BMD), VAT (mass, area, volume) had a significant association with the incidence of non-spine fractures only in nonobese elderly women (VAT mass: OR 1.42, 95 % CI 1.09-1.85, p = 0.010; VAT area: OR 1.19, 95 % CI 1.05-1.36, p = 0.008; VAT volume: OR 1.40, 95 % CI 1.09-1.80, p = 0.009). Conclusion: This study suggests a potential negative effect of visceral adiposity on bone health in nonobese women
Mitchell, Sarah L. "Quadriceps function in elderly patients after proximal femoral fracture." Thesis, University of Glasgow, 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.250054.
Full textEkman, Anna. "Hips at risk osteoporosis and prevention of hip fractures." Doctoral thesis, Uppsala : Acta Universitatis Upsaliensis : Univ.-bibl. [distributör], 2001. http://publications.uu.se/theses/91-554-4930-1/.
Full textKeen, Richard William. "Genetic epidemiology of postmenopausal osteoporosis." Thesis, King's College London (University of London), 2000. https://kclpure.kcl.ac.uk/portal/en/theses/genetic-epidemiology-of-postmenopausal-osteoporosis(15d66e32-f0bb-4b51-9e82-60646699d319).html.
Full textHenderson, Simon Alan. "Exercise, diet and dynamic bone metabolism in osteoporosis." Thesis, Queen's University Belfast, 1991. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.336730.
Full textTuck, Stephen Paul. "The pathogenesis of osteoporosis and low trauma fractures in men." Thesis, University of Leeds, 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.438492.
Full textKarlsson, Elin. "Investigation and treatment after an osteoporotic fracture: : A survey of the Fracture Liaison Service in Örebro County." Thesis, Örebro universitet, Institutionen för medicinska vetenskaper, 2019. http://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-72999.
Full textPilon, Danielle. "Oral anticoagulants and the risk of an osteoporotic fracture among the elderly." Thesis, McGill University, 2001. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=33823.
Full textMethods. We conducted a case-control study on subjects aged 70 years and older enrolled in the Quebec health insurance plan between 1992 and 1994. Incident cases of an osteoporotic fracture (index event) were identified by ICD-9 codes and surgical procedure codes. Exposure defined as one or more prescriptions of oral anticoagulants dispensed before the index event. Ten controls for each case, matched by age and date of index event, were selected.
Results. Among 1,523 cases, 48 (3.2%) were exposed to oral an anticoagulant; among 15,205 controls, 461 (3.0%) were exposed (adjusted odds ratio: 1.1, 95% CI: 0.8--1.4). These negative results persisted after stratifying the exposure into the cumulative dose and duration of treatment.
Conclusions. Oral anticoagulants are not significantly associated with an osteoporotic fracture in the elderly.
Beavan, S. R. "The biochemical and genetic basis of ethnic differences in osteoporotic fracture incidence." Thesis, University of Cambridge, 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.596507.
Full textKATO, FUMIHIKO, NAOKI ISHIGURO, MASAAKI MACHINO, KEIGO ITO, YASUTSUGU YUKAWA, and HIROAKI NAKASHIMA. "COMBINED POSTERIOR-ANTERIOR SURGERY FOR OSTEOPOROTIC DELAYED VERTEBRAL FRACTURE WITH NEUROLOGIC DEFICIT." Nagoya University School of Medicine, 2014. http://hdl.handle.net/2237/20549.
Full textBeavan, Siân Rachel. "The nutritional and biochemical basis of ethnic differences in osteoporotic fracture incidence." Thesis, University of Cambridge, 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.625086.
Full textHartikka, H. (Heini). "Genetic factors in bone disorders:osteogenesis imperfecta, juvenile osteoporosis and stress fractures." Doctoral thesis, University of Oulu, 2005. http://urn.fi/urn:isbn:951427718X.
Full textHeijckmann, Anna Caroline. "Bone mass and fractures in patients at risk for secondary osteoporosis." Maastricht : Maastricht : University Press Maastricht ; University Library, Universiteit Maastricht [host], 2007. http://arno.unimaas.nl/show.cgi?fid=9701.
Full textLöfman, Owe. "Osteoporosis in women : epidemiological and diagnostic perspectives /." Linköping : Univ, 2002. http://www.bibl.liu.se/liupubl/disp/disp2002/med737s.pdf.
Full textRazmkhah, Omid. "Effect of sideways impact fall on the osteoporosis fractures of proximal femur." Thesis, Kingston University, 2014. http://eprints.kingston.ac.uk/28910/.
Full textSmith, Matthew S. "Bone fracture toughness of estrogen deficient rabbits." Morgantown, W. Va. : [West Virginia University Libraries], 2003. http://etd.wvu.edu/templates/showETD.cfm?recnum=3094.
Full textTitle from document title page. Document formatted into pages; contains x, 100 p. : ill. (some col.). Includes abstract. Includes bibliographical references (p. 91-96).
Bidesi, Anup Singh. "Comparison of texture classification methods to evaluate spongy bone texture in osteoporosis /." free to MU campus, to others for purchase, 2004. http://wwwlib.umi.com/cr/mo/fullcit?p1422912.
Full textPande, Ira. "Causes and consequences of hip fracture in men." Thesis, King's College London (University of London), 2000. https://kclpure.kcl.ac.uk/portal/en/theses/causes-and-consequences-of-hip-fracture-in-men(936ddf70-60c5-412c-8508-a12c9570ada7).html.
Full textSeemun, Ray [Verfasser]. "Effects of strontium loaded calcium phosphate cement on osteoporotic fracture defect healing / Ray Seemun." Gießen : Universitätsbibliothek, 2014. http://d-nb.info/1068825987/34.
Full textCzech, Tori. "Fabrication of Osteogenic Protein-loaded Thermoresponsive Hydrogels and Translational Assessment for Osteoporotic Fracture Healing." NEOMED Integrated Pharmaceutical Medicine / OhioLINK, 2021. http://rave.ohiolink.edu/etdc/view?acc_num=ne2mh1614181385140819.
Full text